Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Purpose</h3><p>Accurately delineating clinical target volumes (CTV) is essential for completing radiotherapy plans but is time‐consuming, labor‐intensive and prone to inter‐observer variation. Automating CTV delineation has the benefits of both speeding up contouring process and improving the quality of contours. Recently, auto‐segmentation approaches based on deep learning have achieved some improvements. However, unlike organ segmentation, the CTV contains potential tumor spread tissues or subclinical disease tissues, resulting in poorly defined margin interface and irregular shape. It is not reasonable to directly apply the deep learning segmentation algorithms to CTV tasks without considering the unique characteristics of shape and margin. In this work, we propose a novel automatic CTV delineation algorithm based on deep learning addressing the unique shape and margin challenges.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>Our deep learning method, called RA‐CTVNet, segments the CTV from cervical cancer CT images. RA‐CTVNet denotes our automatic CTV delineation algorithm based on deep learning with Area‐aware reweight strategy and Recursive refinement strategy. (1) In order to process the whole‐volume CT images and delineate all CTVs in one shot, our method is built upon the popular 3D Unet architecture. We further extend it with robust residual learning and squeeze‐and‐excitation blocks for better feature representation.(2) We propose area‐aware reweight strategy which assigns different weights for different slices. The core is adjusting model's attention to each slice. (3) In terms of the trade‐off between providing performance improvements and meeting the limitations of GPU memory, we exploit a new recursive refinement strategy to address margin challenge.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>This retrospective study included 462 patients diagnosed with cervical cancer who received radiotherapy from June 2017 to May 2019. Extensive experiments were conducted to evaluate performance of RA‐CTVNet. First, compared to different network architectures, RA‐CTVNet achieved improvements in Dice similarity coefficient (DSC). Second, we conducted ablation study. The results showed that compared to the backbone, area‐aware reweight strategy increased DSC by 3.3% on average and recursive refinement strategy further increased DSC by 1.6% on average. Then, we compared our method with three human experts. Our RA‐CTVNet performed better than two experts while comparably to the third expert. Finally, multicenter evaluation was conducted to verify the accuracy and generalizability.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>Our findings show that deep learning is able to offer an efficient frame‐work for automatic CTV delineation. The tailored RA‐CTVNet can improve the quality of CTV contours, which has great potential for reducing the burden of experts and increasing the accuracy of delineation. In the future, if with more training data, further improvements are possible, bringing this approach closer to real clinical practice.</p></section>

Clinical evaluation of deep learning-based clinical target volume auto-segmentation algorithm for cervical cancer

Automated Clinical Target Volume Delineation for Non-Small Cell Lung Cancer Patients Using Deep 3D Networks

Automated Clinical Target Volume Delineation Using Deep 3D Neural Networks in Radiation Therapy of Non-small Cell Lung Cancer

Evaluation of Deep Learning‐based Auto‐segmentation Algorithms for Delineating Clinical Target Volume and Organs at Risk Involving Data for 125 Cervical Cancer Patients

Clinical Evaluation of Deep Learning–based Clinical Target Volume Three-Channel Auto-Segmentation Algorithm for Adaptive Radiotherapy in Cervical Cancer

Deep learning‐based auto‐segmentation of clinical target volumes for radiotherapy treatment of cervical cancer

Automatic clinical target volume delineation for cervical cancer in CT images using deep learning

Clinical evaluation of deep learning-based automatic clinical target volume segmentation: a single-institution multi-site tumor experience

Automatic delineation of cervical cancer target volumes in small samples based on multi-decoder and semi-supervised learning and clinical application

An Adversarial Deep-Learning-Based Model for Cervical Cancer CTV Segmentation With Multicenter Blinded Randomized Controlled Validation

Clinical target volume (CTV) automatic delineation using deep learning network for cervical cancer radiotherapy: A study with external validation

Three-dimensional Deep Neural Network for Automatic Delineation of Cervical Cancer in Planning Computed Tomography Images

Clinical Application and Improvement of a CNN-based Autosegmentation Model for Clinical Target Volumes in Cervical Cancer Radiotherapy

A Feasibility Study of Deep Learning-Based Auto-Segmentation Directly Used in VMAT Planning Design and Optimization for Cervical Cancer

Quantitative Comparisons of Deep-learning-based and Atlas-based Auto-segmentation of the Intermediate Risk Clinical Target Volume for Nasopharyngeal Carcinoma.

Deep learning based clinical target volumes contouring for prostate cancer: Easy and efficient application

Clinical evaluation on automatic segmentation results of convolutional neural networks in rectal cancer radiotherapy

CT based automatic clinical target volume delineation using a dense-fully connected convolution network for cervical Cancer radiation therapy

Automated Segmentation of the Clinical Target Volume in the Planning CT for Breast Cancer Using Deep Neural Networks

Clinical application and evaluation of automatic segmentation model based on deep learning for breast cancer radiotherapy

Deep Learning-Aided Automatic Contouring of Clinical Target Volumes for Radiotherapy in Breast Cancer After Modified Radical Mastectomy